4.7 Article

Unilateral Pleural Effusion after Third Dose of BNT162b2 mRNA Vaccination: Case Report

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Estimate false-negative RT-PCR rates for SARS-CoV-2. A systematic review and meta-analysis

Valentina Pecoraro et al.

Summary: A systematic review found that up to 58% of COVID-19 patients may have initial false-negative RT-PCR results, highlighting the need for a correct diagnostic strategy. Additionally, the rate of misdiagnosis may increase with higher disease prevalence.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Cardiac & Cardiovascular Systems

Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series

Dae Yong Park et al.

Summary: COVID-19 vaccine-associated myocarditis usually occurs 3-4 days after receiving the second dose of COVID vaccine in young males, presenting with chest pain, elevated troponin, and ST elevation on electrocardiography. Prognosis is generally favorable.

CLINICAL CARDIOLOGY (2022)

Review Virology

Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis

Sawai Singh Rathore et al.

Summary: This systematic review and meta-analysis evaluated the correlation between COVID-19 disease and pleural effusion, finding that pleural effusion is associated with increased risk of disease severity and mortality. The presence of pleural effusion can serve as a prognostic factor in predicting worse outcomes in COVID-19 patients, suggesting early management for hospitalized patients with pleural effusion.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Medicine, General & Internal

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature

Samantha Lane et al.

Summary: Spontaneously reported data from multiple countries were combined to estimate the reporting rate of myocarditis and pericarditis following COVID-19 mRNA vaccines. The analysis showed that younger individuals are more likely to report these adverse events compared to older individuals. The findings were consistent with published literature.

BMJ OPEN (2022)

Article Medicine, General & Internal

Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy

Hiroshi Shimagami et al.

Summary: Exacerbation of rheumatic disease has been reported after SARS-CoV-2 vaccination, although there are few cases of new-onset rheumatic diseases. We present two cases of new-onset persistent polyarthritis following mRNA vaccination against SARS-CoV-2. One patient developed bilateral pleural effusions with significantly elevated serum interferon (IFN)-beta levels, while the other patient had no effusion and serum IFN-beta levels comparable to healthy individuals. Treatment with 20 mg prednisolone was effective for both patients. Although further investigations are needed, the marked increase in serum IFN-beta levels observed in the patient with pleural effusion may suggest an excessive response from the innate immune system to mRNA vaccines.

BMJ CASE REPORTS (2022)

Article Respiratory System

IgG4 related pleural disease: Recurrent pleural effusion after COVID-19 vaccination

Saria Tasnim et al.

Summary: IgG4-related lung disease (IgG4-RLD) is a systemic fibroinflammatory condition characterized by infiltration of organs by plasma cells with IgG4. This case report describes a patient who developed pleural effusion after receiving the Pfizer COVID-19 vaccine and was subsequently diagnosed with IgG4-RLD. The biopsy confirmed the diagnosis by showing pleural fibrosis, lymphoplasmacytic infiltrates, and increased IgG4-positive plasma cells.

RESPIROLOGY CASE REPORTS (2022)

Article Medicine, General & Internal

Pleural effusion as an indicator for the poor prognosis of COVID-19 patients

Xiao-Shan Wei et al.

Summary: Pleural effusion was observed in 9.19% of COVID-19 patients, who were more likely to be severe or critical cases with increased mortality. Patients with pleural effusion required a longer time to resolve lung inflammation after recovery, indicating a poor prognosis.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Letter Virology

Herpes zoster emergence following mRNA COVID-19 vaccine

Edward Eid et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Infectious Diseases

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety

Maria Teresa Mascellino et al.

Summary: This review discusses the principal vaccines developed against SARS-CoV-2 during the Covid-19 pandemic, evaluating their mechanisms of action, efficacy, safety, and storage temperature. It also delves into dosing issues, vaccination strategies, monoclonal antibodies, and the challenges posed by virus variants. The review highlights the varying efficacy of different vaccines and emphasizes the importance of vaccination strategies based on age groups to achieve herd immunity quickly.

INFECTION AND DRUG RESISTANCE (2021)

Review Medicine, General & Internal

Pleural Disease

David Feller-Kopman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Letter Dermatology

Herpes zoster complicated by unilateral pleural effusion

Liang He et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2018)

Article Medicine, General & Internal

Differentiating between malignant and idiopathic pleural effusions:: the value of diagnostic procedures

C. Aleman et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2007)